Morphine Sulfate generic
morphine sulfate is a potent pain management medication owned by Fresenius Kabi Usa. The active ingredient in this drug is morphine sulfate. It was first authorized for market use on October 30, 2013. It is available in solution form for intramuscular and intravenous application.
When will Morphine Sulfate generic be available?
The patents for Morphine Sulfate are set to expire on March 12, 2034, after which the release of Morphine Sulfate generics may be possible. This drug has a total of 3 patents, all of which are still valid.
Morphine Sulfate uses
morphine sulfate is primarily used for the management of chronic pain in patients requiring opioid analgesia. It is also an effective treatment for general pain management.
Morphine Sulfate patent expiration
Morphine Sulfate, as mentioned above, holds three patents. The last of these is due to expire on March 12, 2034, upon which the release of Morphine Sulfate generics will be possible. Below are the details of the patents: